prednisolone has been researched along with Berger Disease in 147 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Warfarin is a widely used oral anticoagulant drug that has rarely been associated with leukocytoclastic vasculitis and allergic interstitial nephritis." | 5.56 | Ulcerative IgA vasculitis in the setting of warfarin therapy. ( Akay, BN; Boyvat, A; Heper, A; Kalay-Yildizhan, I, 2020) |
| "In 27 IgA nephropathy patients who received 2-year prednisolone treatment, we analyzed the differences in clinical and pathological parameters (1) between patients with and without disappearance of proteinuria (less than 0." | 5.11 | Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day. ( Fujigaki, Y; Hishida, A; Kimura, M; Ohura, M; Suzuki, T; Yamamoto, T; Yonemura, K, 2004) |
| " Patients with high proteinuria and high histological activity were treated with prednisolone." | 5.11 | The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. ( Honda, K; Moriyama, T; Nihei, H; Nitta, K; Yumura, W, 2004) |
| " Because the effect of steroid therapy to prevent the progression of IgA nephropathy is believed to be linked closely to reduction in urinary protein, an insufficient dose of prednisolone in our protocol may be the reason for the discrepancy between the effect on proteinuria and kidney survival." | 5.10 | Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy. ( Ando, T; Fujimi, S; Ikeda, K; Katafuchi, R; Kubo, M; Masutani, K; Mizumasa, T; Tanaka, H; Yanase, T, 2003) |
| " Renal tubular acidosis (RTA) was treated with alkali replacement and moderate-severe tubulointerstitial nephritis (TIN) was treated with oral prednisolone." | 3.88 | Renal involvement in primary Sjogren's syndrome: a prospective cohort study. ( Emmanuel, D; Jain, A; Jain, VK; Negi, VS; Parameshwaran, S; Srinivas, BH, 2018) |
| "Children with IgA nephropathy showing diffuse (>80%) mesangial proliferation are at high risk for end-stage renal failure (ESRF)." | 3.85 | Long-term results of a randomized controlled trial in childhood IgA nephropathy. ( Hataya, H; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kamei, K; Nakanishi, K; Saito, M; Sako, M; Yoshikawa, N, 2011) |
| "A 46-year-old man who was diagnosed with IgA vasculitis (IgAV) at the age of 38 was treated with prednisolone and mizoribine." | 3.85 | A novel case of renal pathergy reaction in a Behçet's disease patient complicated by IgA vasculitis. ( Higashihara, T; Ishigaki, K; Kusano, T; Okada, A; Shimizu, A; Takano, H, 2017) |
| " The patients had IgAN featuring persistent proteinuria and diffuse mesangial proliferation and had failed to respond to 2 years of treatment with prednisolone." | 3.74 | Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy. ( Ikezumi, Y; Karasawa, T; Kawachi, H; Nikolic-Paterson, DJ; Suzuki, T; Uchiyama, M, 2008) |
| "Treatment with prednisolone and azathioprine is beneficial in ameliorating the clinical course of a subset of IgAN patients with heavy proteinuria or impaired renal function." | 3.72 | Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study. ( Ahuja, M; Brown, CB; Davlouros, P; El Nahas, AM; Goumenos, DS; Shortland, JR; Vlachojannis, JG, 2003) |
| "3%) (Group 1) reached a complete remission of proteinuria by prednisolone alone." | 3.72 | Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes. ( Chen, CH; Chen, KJ; Cheng, CH; Shu, KH; Wu, MJ, 2003) |
| "Lamivudine (100 mg/day) was administrated 2 weeks before starting prednisolone and maintained 6 months after prednisolone withdrawal." | 2.79 | Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study. ( Fang, J; Li, D; Li, W; Tan, Z, 2014) |
| "Indication of tonsillectomy in IgA nephropathy is controversial." | 2.77 | Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy. ( Endo, G; Hamada, M; Hayashi, T; Imanishi, M; Kishida, M; Kitabayashi, C; Konishi, M; Konishi, Y; Maeda, I; Morikawa, T; Okada, N; Okumura, M; Sato, KK; Shibata, MO, 2012) |
| "Treatment with prednisolone combined with valsartan effectively decreased both chymase-positive mast cells and RI, displaying a significant correlation between these biomarkers (rho=0." | 2.73 | Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartan. ( Imanishi, M; Kitabayashi, C; Konishi, Y; Maeda, I; Miyazaki, M; Morikawa, T; Nishiyama, A; Okada, N; Okumura, M; Takai, S; Ueda, M; Yoshioka, K, 2008) |
| "IgA nephropathy was subclassified according to Haas criteria." | 2.73 | Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy. ( Alonso, M; Forrester, M; Iotti, A; Iotti, R; Lombi, F; Muryan, A; Pereyra, H; Seminario, O; Trimarchi, H; Young, P, 2007) |
| "Treatment options for progressive IgA nephropathy are limited." | 2.73 | Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy. ( Ashida, R; Furusu, A; Hiu, M; Horita, Y; Kohno, S; Tadokoro, M; Taguchi, T; Taura, K, 2007) |
| " Both groups received methylprednisolone intravenously, followed by oral prednisolone (initial dosage 0." | 2.73 | Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. ( Fujimoto, S; Hara, S; Kitamura, K; Komatsu, H; Sato, Y; Yamada, K, 2008) |
| "No satisfactory treatment exists for IgA nephropathy (IgAN), especially in patients with severe histologic damage." | 2.71 | A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial. ( Kanno, Y; Nakamoto, H; Nemoto, H; Okada, H; Sugahara, S; Suzuki, H; Witt, M, 2003) |
| "For advanced progressive primary IgA nephropathy (IgAN) no established therapy exists." | 2.71 | Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy. ( Czock, D; Jehle, PM; Karges, W; Keller, F; Klotz, CH; Mertz, A; Muche, R; Rasche, FM, 2003) |
| "After 1 year of treatment, proteinuria significantly decreased in the corticosteroid group." | 2.69 | Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. ( Hayashi, T; Hori, M; Imai, E; Nakanishi, I; Okada, N; Shoji, T; Suzuki, A; Togawa, M; Tsubakihara, Y, 2000) |
| "Treatment with prednisolone, azathioprine, heparin-warfarin, and dipyridamole early in the course of disease may prevent immunologic renal injury in children with severe IgA nephropathy." | 2.69 | A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. ( Awazu, M; Hattori, S; Honda, M; Iitaka, K; Ito, H; Ito, K; Koitabashi, Y; Matsuyama, S; Nakagawa, K; Nakamura, H; Ninomiya, M; Sakai, T; Seino, Y; Takeda, N; Takekoshi, Y; Yamaoka, K; Yoshikawa, N, 1999) |
| "Eighteen children with IgA nephropathy met study criteria." | 2.69 | Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy. ( Tanaka, H; Waga, S; Yokoyama, M, 1998) |
| "The early stage of progressive IgA nephropathy was defined as having moderate proteinuria between 1 and 2 g/day, creatinine clearance values of 70 ml/min or more, and a histological severity score of 7 or more." | 2.68 | Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. ( Hiki, Y; Horii, A; Kobayashi, Y; Kokubo, T; Tateno, S, 1996) |
| "We report a 10-year-old boy with juvenile dermatomyositis and IgA nephropathy." | 2.61 | Juvenile dermatomyositis with IgA nephropathy: case-based review. ( Bagri, NK; Barwad, A; Hari, P; Mantoo, MR; Phulware, RH; Tripathy, SK, 2019) |
| "With treatment of prednisolone, an angiotensin-converting enzyme inhibitor, and an angiotensin II receptor-blocker, his proteinuria markedly decreased and renal function was stabilized." | 2.43 | Nephrotic syndrome and IgA nephropathy in polycystic kidney disease. ( Gejyo, F; Hiura, T; Kawabe, S; Miyamura, S; Nishi, S; Saeki, T; Ueno, M; Yamazaki, H, 2006) |
| "We diagnosed highly active IgA nephropathy and initiated treatment with prednisolone and azathioprine." | 1.91 | IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration. ( Hattori, K; Ishikawa, R; Shimizu, R; Tamai, H; Tanaka, S; Terashima, T; Watanabe, T; Yamazaki, M, 2023) |
| "From a total of 1,174 IgAN patients in a multicenter retrospective cohort analysis in Japan, 195 patients were treated by tonsillectomy combined with corticosteroid." | 1.62 | Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan. ( Hirano, K; Kataoka, H; Kawamura, T; Koike, K; Maruyama, S; Matsuo, S; Matsuzaki, K; Moriyama, T; Nitta, K; Suzuki, Y; Yasuda, T; Yasuda, Y; Yokoo, T, 2021) |
| "Crescent formation in immunoglobulin A nephropathy (IgAN) has been demonstrated to be a risk factor for worse outcomes." | 1.56 | Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents. ( Chen, J; Li, C; Lin, L; Liu, S; Peng, Z; Xu, H; Zhu, X, 2020) |
| "Warfarin is a widely used oral anticoagulant drug that has rarely been associated with leukocytoclastic vasculitis and allergic interstitial nephritis." | 1.56 | Ulcerative IgA vasculitis in the setting of warfarin therapy. ( Akay, BN; Boyvat, A; Heper, A; Kalay-Yildizhan, I, 2020) |
| "We collected data for 44 IgA nephropathy children treated with multi-drug combination therapy." | 1.48 | Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy. ( Hosoya, M; Kawasaki, Y; Maeda, R; Ohara, S; Suyama, K, 2018) |
| "Treatment of IgA nephropathy (IgAN) in Japan has recently changed, from oral prednisolone (oPSL) to tonsillectomy plus steroid pulse (TSP) therapy." | 1.46 | Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy. ( Hoshino, Y; Moriyama, T; Nitta, K; Tsuchiya, K; Uchida, K, 2017) |
| "Single-course steroid pulse therapy combined with mizoribine was considered to have a protective effect on the renal function in IgA nephropathy, especially accompanying renal dysfunction." | 1.42 | Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine. ( Arai, M; Hirama, A; Ikeda, M; Kaneko, T; Morita, M; Shimizu, A; Tsuruoka, S; Watanabe, Y, 2015) |
| "Some patients with severe immunoglobulin A nephropathy (IgAN) are resistant to multi-drug combination therapy; however, there have been few reports on the risk factors for non-responsiveness to treatment for severe IgAN." | 1.40 | Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation. ( Hashimoto, K; Hosoya, M; Kanno, S; Kawasaki, Y; Miyazaki, K; Ono, A; Sato, M; Suyama, K; Suzuki, Y, 2014) |
| "Clinicians should recognize that tubulointerstitial nephritis and uveitis syndrome with immunoglobulin A nephropathy can occur in the presence of Graves' disease." | 1.40 | Tubulointerstitial nephritis and uveitis syndrome complicated by IgA nephropathy and Graves' disease: a case report. ( Hasegawa, K; Moniwa, N; Ogawa, Y; Shimamura, Y; Takizawa, H; Tsushima, T, 2014) |
| "A 76-year-old man with a history of type 2 diabetes mellitus was admitted with cholangitis caused by cholangiocarcinoma." | 1.40 | IgA-dominant postinfectious glomerulonephritis associated with Escherichia coli infection caused by cholangitis. ( Aki, S; Aoyagi, M; Arai, Y; Hirasawa, S; Inaba, N; Kikuchi, H; Nagahama, K; Tamura, T; Tanaka, H; Yamamura, C, 2014) |
| "Oral prednisolone (30 mg/day) was then given on alternative days and gradually tapered and finished over 1 year." | 1.39 | Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients. ( Mima, T; Minami, Y; Negi, S; Ohya, M; Otani, H; Shigematsu, T; Yamanaka, S; Yukawa, S, 2013) |
| "Because of this course, we diagnosed minimal change nephrotic syndrome complicated by mild-proliferative IgA nephropathy." | 1.38 | A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis. ( Hirose, M; Kawazu, T; Kitamura, M; Kohno, S; Miyazaki, M; Nishino, T; Obata, Y; Taguchi, T; Uramatsu, T, 2012) |
| "In 2009, the Oxford classification of IgA nephropathy was published." | 1.38 | Validity of the Oxford classification of IgA nephropathy in children. ( Hama, T; Hashimura, Y; Iijima, K; Kaito, H; Mukaiyama, H; Nakanishi, K; Sako, M; Shima, Y; Togawa, H; Yoshikawa, N, 2012) |
| "Patients with IgA nephropathy (IgAN) often show aggravation of renal injury with macroscopic hematuria after mucosal infections, especially tonsillitis." | 1.38 | Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients. ( Horikoshi, S; Ikeda, K; Kano, T; Matsuoka, J; Sato, D; Suzuki, H; Suzuki, Y; Tomino, Y; Yokoi, H, 2012) |
| "The prognosis of children with severe IgA nephropathy showing diffuse mesangial proliferation is poor." | 1.37 | Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy. ( Iijima, K; Kamei, K; Nakanishi, K; Nozu, K; Sasaki, S; Shima, Y; Tanaka, R; Togawa, H; Yoshikawa, N, 2011) |
| "He was being treated for alcoholic liver cirrhosis, but as bloody urine was noticed macroscopically, his renal function rapidly decreased." | 1.37 | [Two cases of rapidly progressive nephritic syndrome complicated with alcoholic liver cirrhosis]. ( Aoki, M; Arakawa, Y; Arima, R; Fujita, E; Fukuda, K; Fukui, M; Hirama, A; Iino, Y; Kaneko, T; Mii, A; Shimizu, A; Utsumi, K, 2011) |
| "The microscopic examination showed IgA nephropathy with crescent formation, accompanied by mild lymphoplasmacytic tubulointerstitial nephritis." | 1.37 | [Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease]. ( Fujii, A; Fujiwara, H; Ishimoto, Y; Kotera, N; Kurita, N; Mise, N; Sugimoto, T; Tanaka, M; Tanaka, S; Yamaguchi, Y, 2011) |
| "Our case is unique in respect of the recurrence at more than 3 years after the complete resolution of initial symptoms, suggesting that careful followup is required in spite of improved renal symptoms in cases of HSP." | 1.36 | A case of Henoch-Schoenlein purpura nephritis recurring after 3 years remission. ( Haneda, K; Hashimoto, K; Hosoya, M; Kaneko, M; Kawasaki, Y; Sakai, N; Suyama, K; Ushijima, Y, 2010) |
| "The effectiveness of steroid pulse therapy combined with tonsillectomy (ST) has been shown in immunoglobulin A nephropathy (IgAN) patients with moderate or severe urinary abnormalities." | 1.36 | Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria. ( Fukuhara, S; Gillespie, B; Hayashino, Y; Hotta, O; Ieiri, N; Kawaguchi, T; Miyazaki, M; Taguma, Y; Yamazaki, S, 2010) |
| "The benefits of steroid therapy in immunoglobulin A nephropathy (IgAN) have not been established." | 1.35 | The improvement of renal survival with steroid pulse therapy in IgA nephropathy. ( Hirakata, H; Ikeda, K; Katafuchi, R; Kumagai, H; Mizumasa, T; Nagata, M; Ninomiya, T, 2008) |
| "The findings suggest that the thrombus formation may have been associated with the small shunt and/or prednisolone." | 1.35 | A ball-shaped thrombus of the tricuspid valve after VSD closure. ( Kanemitsu, S; Miyagawa, H; Miyake, Y; Ohue, K; Okabe, M; Tanabe, S, 2009) |
| "IgA nephropathy is the most common type of the glomerulonephritis all over the world." | 1.35 | Minimal change disease versus IgA nephropathy. ( Jabur, WL, 2009) |
| "A case of PSGN during IgA nephropathy is presented." | 1.35 | Acute poststreptococcal glomerulonephritis superimposed on IgA nephropathy. ( Lee, KW; Lim, BJ; Na, KR; Shin, YT; Suh, KS, 2008) |
| "We report a rare case of IgA nephropathy (IgAN), that was considered as showing tonsillar focal infection, involving pulmoplantar pustulosis (PPP), and sternocostoclavicular hyperosteosis (SCCH)." | 1.34 | Tonsillar focal infectious disease involving IgA nephropathy, pustulosis, and ossification. ( Kodama, S; Noda, K; Suenaga, S; Suzuki, M, 2007) |
| "She was diagnosed with IgA nephropathy with a poor prognosis, based on the formation of many crescents in the glomerulus and monocyte infiltration in the interstitium in a renal biopsy specimen in February 2003." | 1.34 | MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomy. ( Muso, E; Nishiki, M; Ogawa, N; Sugimoto, T; Tsukamoto, T; Yamaguchi, T; Yamane, Y; Yano, S, 2007) |
| "We report a case of IgA nephropathy with tuberculous pleurisy that was treated with steroid pulse therapy combined with tonsillectomy." | 1.33 | [Steroid pulse therapy combined with tonsillectomy in a patient with IgA nephropathy complicated with tuberculous pleurisy]. ( Koike, K; Okuda, S; Sugawara, K; Takeda, K; Tamaki, K; Wakasugi, D, 2005) |
| "We report a female patient with IgA nephropathy associated with undifferentiated spondyloarthropathy." | 1.33 | Coexistence of IgA nephropathy and undifferentiated spondyloarthropathy in a female patient. ( Ikeda, S; Matsuda, M; Miyagawa, H; Shimizu, S; Suzuki, A, 2006) |
| "The pathogenesis of IgA nephropathy is still unknown, and treatment remains controversial." | 1.33 | Unusual presentation of IgA nephropathy in childhood: a case report. ( Agras, PI; Baskin, E; Bilezikci, B; Cengiz, N; Saatci, U, 2005) |
| "Steroid therapy for IgA nephropathy (IgAN) has been reported to ameliorate the long-term prognosis of IgAN, but its mode of action has not been fully elucidated." | 1.32 | Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy. ( Asahi, K; Asano, K; Eiro, M; Katoh, T; Kuriki, M; Sakurai, K; Suzuki, H; Watanabe, K; Watanabe, T, 2003) |
| "We describe a patient with IgA nephropathy associated with Crohn disease." | 1.31 | An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications. ( Kuwajima, H; Okada, M; Takemura, T; Yagi, K; Yanagida, H, 2002) |
| "For a long time, this type of recurrence was considered as a benign condition." | 1.31 | An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy. ( Benabdallah, L; Bruneel, MF; Carron, PL; Kreis, H; Morelon, E; Noël, LH; Peraldi, MN; Rerolle, JP, 2002) |
| "These data suggest that IgA nephropathy associated with severe inflammatory and crescenteric change can be effectively and safely treated with a low-cost regime based on oral corticosteroids and cyclophosphamide tailored to a plateau of treatment response in individual patients." | 1.31 | Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment. ( Fluck, RJ; Lambie, SH; McIntyre, CW, 2001) |
| "Ten patients with biopsy-confirmed IgA nephropathy associated with diabetes mellitus underwent dietary weight control and three courses of intravenous pulses of methylprenisolone followed by prednisolone for 6-12 months and tonsillectomy." | 1.31 | Steroid pulse therapy combined with tonsillectomy in IgA nephropathy associated with diabetes mellitus. ( Chiba, S; Furuta, T; Honda, S; Horigome, I; Hotta, O; Miyazaki, M; Noshiro, H; Satoh, M; Taguma, Y, 2001) |
| "Although recurrence of IgA nephropathy in renal allograft is frequent, allograft dysfunction is rare." | 1.30 | [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)]. ( Hatori, M; Honda, M; Ichimaru, N; Imai, E; Kokado, Y; Kyo, M; Matsumiya, K; Miyamoto, M; Nonomura, N; Okuyama, A; Takahara, S; Takao, T; Yokoyama, K, 1997) |
| "In this study progressive IgA nephropathy was defined as follows; 24 hour urinary protein excretion was (++) or more and renal biopsy carried out just before the therapy revealed crescents, inevitably including cellular crescents, in 10% or more glomeruli observed." | 1.28 | [Effects of methylprednisolone pulse therapy on progressive IgA nephropathy]. ( Kida, H; Saito, Y; Sugioka, G; Takaeda, M; Yoshimura, M, 1991) |
| "We describe a patient with Berger's disease and polyarteritis nodosa." | 1.28 | Berger's disease with polyarteritis nodosa. ( Corti, C; Praderio, L; Sabbadini, MG; Sposato, E; Taccagni, GL; Volpi, A, 1989) |
| "29 patients with IgA nephropathy whose proteinuria persisted at a level of 2." | 1.27 | Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases. ( Fujii, K; Hiki, Y; Kamiyama, M; Kobayashi, Y; Kurokawa, A; Tateno, S, 1988) |
| "Forty-three patients with IgA nephropathy whose proteinuria persisted between 1." | 1.27 | Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases. ( Fujii, K; Hiki, Y; Kobayashi, Y; Tateno, S, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (10.20) | 18.7374 |
| 1990's | 27 (18.37) | 18.2507 |
| 2000's | 52 (35.37) | 29.6817 |
| 2010's | 43 (29.25) | 24.3611 |
| 2020's | 10 (6.80) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, T | 1 |
| Takeuchi, K | 1 |
| Ishikawa, A | 1 |
| Terasaki, M | 1 |
| Arai, Y | 2 |
| Hatanaka, S | 1 |
| Hirano, Y | 1 |
| Miyazaki, S | 1 |
| Hoashi, T | 1 |
| Mii, A | 2 |
| Saeki, H | 1 |
| Sakai, Y | 1 |
| Shimizu, A | 5 |
| Ikezumi, Y | 2 |
| Yoshikane, M | 1 |
| Kondoh, T | 1 |
| Matsumoto, Y | 1 |
| Kumagai, N | 1 |
| Kaneko, M | 2 |
| Hasegawa, H | 1 |
| Yamada, T | 1 |
| Suzuki, T | 3 |
| Nikolic-Paterson, DJ | 2 |
| Hattori, K | 2 |
| Shimizu, R | 2 |
| Tanaka, S | 3 |
| Terashima, T | 2 |
| Ishikawa, R | 2 |
| Yamazaki, M | 2 |
| Watanabe, T | 3 |
| Tamai, H | 2 |
| Chen, J | 1 |
| Xu, H | 1 |
| Peng, Z | 1 |
| Lin, L | 1 |
| Li, C | 1 |
| Zhu, X | 1 |
| Liu, S | 1 |
| Ni, J | 1 |
| Zhu, C | 1 |
| Ni, X | 1 |
| Yin, J | 1 |
| Rao, N | 1 |
| Bendall, A | 1 |
| Lanteri, M | 1 |
| Selvaskandan, H | 1 |
| Kay Cheung, C | 1 |
| Dormer, J | 1 |
| Wimbury, D | 1 |
| Martinez, M | 1 |
| Xu, G | 1 |
| Barratt, J | 1 |
| Moriyama, T | 7 |
| Kataoka, H | 1 |
| Nitta, K | 7 |
| Hirano, K | 1 |
| Matsuzaki, K | 2 |
| Yasuda, T | 1 |
| Yasuda, Y | 1 |
| Koike, K | 2 |
| Maruyama, S | 1 |
| Yokoo, T | 1 |
| Matsuo, S | 3 |
| Kawamura, T | 4 |
| Suzuki, Y | 4 |
| Kalay-Yildizhan, I | 1 |
| Akay, BN | 1 |
| Boyvat, A | 1 |
| Heper, A | 1 |
| Ogura, S | 1 |
| Miyabe, Y | 1 |
| Karasawa, K | 1 |
| Šterzl, I | 1 |
| Hill, M | 1 |
| Stárka, L | 1 |
| Velíková, M | 1 |
| Kančeva, R | 1 |
| Jemelková, J | 1 |
| Czerneková, L | 1 |
| Kosztyu, P | 1 |
| ZadraŽil, J | 1 |
| Matoušovic, K | 1 |
| Vondrák, K | 1 |
| Raška, M | 1 |
| Tamura, T | 2 |
| Ohara, G | 1 |
| Kagohashi, K | 1 |
| Satoh, H | 1 |
| Kawasaki, Y | 3 |
| Maeda, R | 1 |
| Ohara, S | 1 |
| Suyama, K | 3 |
| Hosoya, M | 3 |
| Iinuma, S | 1 |
| Kanno, K | 1 |
| Honma, M | 1 |
| Kinouchi, M | 1 |
| Ishida-Yamamoto, A | 1 |
| Adachi, M | 1 |
| Sato, M | 3 |
| Miyazaki, M | 5 |
| Hotta, O | 4 |
| Hozawa, K | 1 |
| Sato, T | 2 |
| Taguma, Y | 4 |
| Katori, Y | 1 |
| Shima, Y | 4 |
| Nakanishi, K | 9 |
| Kaku, Y | 2 |
| Ishikura, K | 4 |
| Hataya, H | 3 |
| Matsuyama, T | 1 |
| Honda, M | 6 |
| Sako, M | 5 |
| Nozu, K | 4 |
| Tanaka, R | 3 |
| Iijima, K | 7 |
| Yoshikawa, N | 13 |
| Jain, A | 1 |
| Srinivas, BH | 1 |
| Emmanuel, D | 1 |
| Jain, VK | 1 |
| Parameshwaran, S | 1 |
| Negi, VS | 1 |
| Takada, D | 1 |
| Hoshino, J | 1 |
| Fujii, T | 2 |
| Usui, J | 1 |
| Ohashi, K | 1 |
| Takaichi, K | 1 |
| Suzuki, S | 1 |
| Yamagata, K | 1 |
| Ubara, Y | 1 |
| Mantoo, MR | 1 |
| Tripathy, SK | 1 |
| Phulware, RH | 1 |
| Bagri, NK | 1 |
| Hari, P | 1 |
| Barwad, A | 1 |
| Kondo, N | 1 |
| Tachikawa, M | 1 |
| Tomita, E | 1 |
| Hattori, A | 1 |
| Yamamura, Y | 1 |
| Nonaka, M | 1 |
| Ohashi, N | 1 |
| Tsuji, T | 1 |
| Nagata, S | 1 |
| Naito, T | 3 |
| Yasuda, H | 1 |
| Kawakami, J | 1 |
| Yang, YZ | 1 |
| Chen, P | 1 |
| Liu, LJ | 1 |
| Cai, QQ | 1 |
| Shi, SF | 1 |
| Chen, YQ | 1 |
| Lv, JC | 1 |
| Zhang, H | 1 |
| Nakata, J | 1 |
| Sakamoto, N | 1 |
| Horikoshi, S | 3 |
| Tomino, Y | 3 |
| Ohya, M | 1 |
| Otani, H | 1 |
| Minami, Y | 1 |
| Yamanaka, S | 1 |
| Mima, T | 1 |
| Negi, S | 1 |
| Yukawa, S | 1 |
| Shigematsu, T | 1 |
| Kamei, D | 1 |
| Takei, T | 2 |
| Wakai, S | 1 |
| Fang, J | 1 |
| Li, W | 1 |
| Tan, Z | 1 |
| Li, D | 1 |
| Miyazaki, K | 1 |
| Kanno, S | 1 |
| Ono, A | 1 |
| Hashimoto, K | 2 |
| Gujadhur, A | 1 |
| Thomson, N | 1 |
| Aung, AK | 1 |
| Mclean, C | 1 |
| Menahem, S | 1 |
| Shimamura, Y | 1 |
| Tsushima, T | 1 |
| Moniwa, N | 1 |
| Hasegawa, K | 2 |
| Ogawa, Y | 1 |
| Takizawa, H | 1 |
| Kikuchi, H | 1 |
| Aoyagi, M | 1 |
| Nagahama, K | 1 |
| Yamamura, C | 1 |
| Hirasawa, S | 1 |
| Aki, S | 1 |
| Inaba, N | 1 |
| Tanaka, H | 4 |
| Nishiwaki, H | 1 |
| Hasegawa, T | 1 |
| Nagayama, Y | 1 |
| Kaneshima, N | 1 |
| Takayasu, M | 1 |
| Hirose, M | 2 |
| Komukai, D | 1 |
| Inoue, Y | 1 |
| Koiwa, F | 1 |
| Yoshimura, A | 1 |
| Katafuchi, R | 3 |
| Joh, K | 1 |
| Hashiguchi, A | 1 |
| Hisano, S | 1 |
| Miyazaki, Y | 1 |
| Nagata, M | 2 |
| Ramachandran, R | 1 |
| Doddi, P | 1 |
| Nandakrishna, B | 1 |
| Nada, R | 1 |
| Kumar, V | 1 |
| Rathi, M | 1 |
| Kohli, HS | 1 |
| Jha, V | 1 |
| Sakhuja, V | 1 |
| Gupta, KL | 1 |
| Kaneko, T | 2 |
| Arai, M | 1 |
| Ikeda, M | 1 |
| Morita, M | 1 |
| Watanabe, Y | 1 |
| Hirama, A | 2 |
| Tsuruoka, S | 1 |
| Hoshino, Y | 1 |
| Uchida, K | 2 |
| Tsuchiya, K | 3 |
| Hama, T | 2 |
| Mukaiyama, H | 2 |
| Togawa, H | 3 |
| Suzuki, H | 4 |
| Higashihara, T | 1 |
| Okada, A | 1 |
| Kusano, T | 1 |
| Ishigaki, K | 1 |
| Takano, H | 1 |
| Okamoto, M | 1 |
| Yokoyama, N | 1 |
| Komatsu, H | 1 |
| Fujimoto, S | 1 |
| Hara, S | 1 |
| Sato, Y | 1 |
| Yamada, K | 1 |
| Kitamura, K | 1 |
| Ninomiya, T | 1 |
| Mizumasa, T | 2 |
| Ikeda, K | 3 |
| Kumagai, H | 2 |
| Hirakata, H | 2 |
| Lim, BJ | 1 |
| Suh, KS | 1 |
| Na, KR | 1 |
| Lee, KW | 1 |
| Shin, YT | 1 |
| Konishi, Y | 2 |
| Morikawa, T | 2 |
| Okada, N | 3 |
| Maeda, I | 2 |
| Kitabayashi, C | 2 |
| Yoshioka, K | 2 |
| Okumura, M | 2 |
| Nishiyama, A | 1 |
| Ueda, M | 1 |
| Takai, S | 1 |
| Imanishi, M | 2 |
| Jabur, WL | 1 |
| Choi, S | 1 |
| Lee, D | 1 |
| Jeong, KH | 1 |
| Moon, JY | 1 |
| Lee, SH | 1 |
| Lee, TW | 2 |
| Ihm, CG | 2 |
| Kanemitsu, S | 1 |
| Tanabe, S | 1 |
| Ohue, K | 1 |
| Miyagawa, H | 2 |
| Miyake, Y | 1 |
| Okabe, M | 1 |
| Ito, S | 2 |
| Kamei, K | 4 |
| Ikoma, M | 1 |
| Kawaguchi, T | 1 |
| Ieiri, N | 2 |
| Yamazaki, S | 1 |
| Hayashino, Y | 1 |
| Gillespie, B | 1 |
| Fukuhara, S | 1 |
| Sasaki, S | 1 |
| Arima, R | 1 |
| Arakawa, Y | 1 |
| Aoki, M | 1 |
| Fukuda, K | 1 |
| Fukui, M | 1 |
| Fujita, E | 1 |
| Utsumi, K | 1 |
| Iino, Y | 1 |
| Ushijima, Y | 1 |
| Haneda, K | 1 |
| Sakai, N | 1 |
| Saito, M | 1 |
| Fujiwara, H | 1 |
| Mise, N | 1 |
| Ishimoto, Y | 1 |
| Kotera, N | 1 |
| Tanaka, M | 1 |
| Kurita, N | 1 |
| Fujii, A | 1 |
| Yamaguchi, Y | 1 |
| Sugimoto, T | 2 |
| Sato, D | 1 |
| Kano, T | 1 |
| Matsuoka, J | 1 |
| Yokoi, H | 1 |
| Hashimura, Y | 1 |
| Kaito, H | 1 |
| Nishino, T | 1 |
| Uramatsu, T | 1 |
| Obata, Y | 1 |
| Kitamura, M | 1 |
| Kawazu, T | 1 |
| Taguchi, T | 2 |
| Kohno, S | 2 |
| Hayashi, T | 2 |
| Sato, KK | 1 |
| Shibata, MO | 1 |
| Hamada, M | 1 |
| Kishida, M | 1 |
| Konishi, M | 1 |
| Endo, G | 1 |
| Joerg, L | 1 |
| Kerstin, A | 1 |
| Niko, B | 1 |
| Dominik, A | 1 |
| Martin, K | 1 |
| Latus, J | 1 |
| Amann, K | 1 |
| Braun, N | 1 |
| Alscher, MD | 1 |
| Kimmel, M | 1 |
| Ponticelli, C | 1 |
| Watanabe, H | 1 |
| Uruma, T | 1 |
| Tsunoda, T | 1 |
| Ishii, H | 1 |
| Tazaki, G | 1 |
| Kondo, T | 1 |
| Takemura, T | 2 |
| Okada, M | 2 |
| Yagi, K | 2 |
| Kuwajima, H | 1 |
| Yanagida, H | 1 |
| Benabdallah, L | 1 |
| Rerolle, JP | 1 |
| Peraldi, MN | 1 |
| Noël, LH | 1 |
| Bruneel, MF | 1 |
| Carron, PL | 1 |
| Morelon, E | 1 |
| Kreis, H | 1 |
| Goumenos, DS | 1 |
| Davlouros, P | 1 |
| El Nahas, AM | 1 |
| Ahuja, M | 1 |
| Shortland, JR | 1 |
| Vlachojannis, JG | 1 |
| Brown, CB | 1 |
| Feehally, J | 1 |
| Ando, T | 1 |
| Yanase, T | 1 |
| Masutani, K | 1 |
| Kubo, M | 1 |
| Fujimi, S | 1 |
| Rasche, FM | 1 |
| Klotz, CH | 1 |
| Czock, D | 1 |
| Karges, W | 1 |
| Muche, R | 1 |
| Jehle, PM | 1 |
| Mertz, A | 1 |
| Keller, F | 1 |
| Mertens, PR | 1 |
| Floege, J | 1 |
| Kuriki, M | 1 |
| Asahi, K | 1 |
| Asano, K | 1 |
| Sakurai, K | 1 |
| Eiro, M | 1 |
| Watanabe, K | 1 |
| Katoh, T | 1 |
| Chen, KJ | 1 |
| Cheng, CH | 1 |
| Wu, MJ | 1 |
| Chen, CH | 1 |
| Shu, KH | 1 |
| Kanno, Y | 1 |
| Witt, M | 1 |
| Okada, H | 1 |
| Nemoto, H | 1 |
| Sugahara, S | 1 |
| Nakamoto, H | 1 |
| Honda, K | 3 |
| Yumura, W | 2 |
| Nihei, H | 2 |
| Yamamoto, T | 1 |
| Ohura, M | 1 |
| Fujigaki, Y | 2 |
| Yonemura, K | 1 |
| Kimura, M | 2 |
| Hishida, A | 3 |
| van den Berg, JG | 1 |
| van den Bergh Weerman, MA | 1 |
| Assmann, KJ | 1 |
| Weening, JJ | 1 |
| Florquin, S | 1 |
| Tamaki, K | 2 |
| Takeda, K | 1 |
| Sugawara, K | 1 |
| Wakasugi, D | 1 |
| Okuda, S | 2 |
| Matsuda, M | 1 |
| Suzuki, A | 2 |
| Shimizu, S | 1 |
| Ikeda, S | 1 |
| Cengiz, N | 1 |
| Baskin, E | 1 |
| Agras, PI | 1 |
| Bilezikci, B | 1 |
| Saatci, U | 1 |
| Kahn, A | 1 |
| Hodges, N | 1 |
| Lord, M | 1 |
| Hiura, T | 1 |
| Yamazaki, H | 1 |
| Saeki, T | 1 |
| Kawabe, S | 1 |
| Ueno, M | 1 |
| Nishi, S | 1 |
| Miyamura, S | 1 |
| Gejyo, F | 1 |
| Noda, K | 1 |
| Kodama, S | 1 |
| Suenaga, S | 1 |
| Suzuki, M | 1 |
| Horita, Y | 1 |
| Tadokoro, M | 1 |
| Taura, K | 1 |
| Ashida, R | 1 |
| Hiu, M | 1 |
| Furusu, A | 1 |
| Awazu, M | 2 |
| Hattori, S | 2 |
| Ito, H | 4 |
| Yoshikawa, T | 1 |
| Matsuo, T | 1 |
| Masuda, I | 1 |
| Ota, K | 1 |
| Yamadori, I | 1 |
| Sunami, R | 1 |
| Nose, S | 1 |
| Karasawa, T | 1 |
| Kawachi, H | 1 |
| Uchiyama, M | 1 |
| Trimarchi, H | 1 |
| Muryan, A | 1 |
| Young, P | 1 |
| Forrester, M | 1 |
| Iotti, A | 1 |
| Pereyra, H | 1 |
| Lombi, F | 1 |
| Seminario, O | 1 |
| Alonso, M | 1 |
| Iotti, R | 1 |
| Mitsuiki, K | 2 |
| Harada, A | 2 |
| Okura, T | 1 |
| Higaki, J | 1 |
| Ogawa, N | 1 |
| Yano, S | 1 |
| Yamane, Y | 2 |
| Nishiki, M | 2 |
| Yamaguchi, T | 1 |
| Tsukamoto, T | 1 |
| Muso, E | 1 |
| Koike, M | 1 |
| Horita, S | 1 |
| Ogawa, T | 1 |
| Yoshida, T | 1 |
| Igarashi, T | 1 |
| Nakazato, H | 1 |
| Nakamura, H | 2 |
| Yamamoto, Y | 1 |
| Oshima, S | 1 |
| Kawamura, O | 1 |
| Ikegaya, N | 1 |
| Nagase, M | 1 |
| Honda, N | 2 |
| Naruse, T | 1 |
| Reznik, VM | 1 |
| Griswold, WR | 1 |
| Lemire, JM | 1 |
| Mendoza, SA | 1 |
| Sakai, O | 1 |
| Murakami, K | 1 |
| Akano, N | 1 |
| Aya, N | 1 |
| Hino, S | 1 |
| Miyazato, H | 1 |
| Maki, S | 1 |
| Okubo, M | 1 |
| Horata-Takahashi, E | 1 |
| Tamura, K | 1 |
| Kamata, K | 1 |
| Kobayashi, Y | 6 |
| Nakayama, Y | 1 |
| Osakabe, T | 1 |
| Sato, K | 1 |
| Kumano, K | 1 |
| Endo, T | 1 |
| Hiki, Y | 5 |
| Kokubo, T | 1 |
| Horii, A | 1 |
| Tateno, S | 5 |
| Dohi, K | 1 |
| Yamamoto, S | 1 |
| Iesato, K | 1 |
| Yoshida, H | 1 |
| Hori, J | 1 |
| Hasegawa, R | 1 |
| Ohta, Y | 1 |
| Akikusa, B | 1 |
| Kondo, Y | 1 |
| Waga, S | 2 |
| Kakizaki, Y | 1 |
| Sugimoto, K | 1 |
| Yokoyama, M | 2 |
| Matsumoto, K | 5 |
| Akatsuka, T | 1 |
| Kawata, T | 1 |
| Hashimoto, S | 1 |
| Nakamura, S | 1 |
| Koike, T | 1 |
| Ozu, H | 1 |
| Matsugami, K | 1 |
| Takao, T | 1 |
| Hatori, M | 1 |
| Ichimaru, N | 1 |
| Nonomura, N | 1 |
| Matsumiya, K | 1 |
| Kokado, Y | 1 |
| Takahara, S | 1 |
| Okuyama, A | 1 |
| Miyamoto, M | 1 |
| Yokoyama, K | 1 |
| Imai, E | 2 |
| Kyo, M | 1 |
| Sakai, T | 2 |
| Takekoshi, Y | 1 |
| Ito, K | 1 |
| Iitaka, K | 1 |
| Koitabashi, Y | 1 |
| Yamaoka, K | 1 |
| Nakagawa, K | 1 |
| Matsuyama, S | 1 |
| Seino, Y | 1 |
| Takeda, N | 1 |
| Ninomiya, M | 1 |
| Tsuji, Y | 1 |
| Mizuno, Y | 1 |
| Iikura, Y | 1 |
| Murakami, Y | 1 |
| Kato, Y | 1 |
| Tsuruya, K | 1 |
| Johko, T | 1 |
| Kondoh, H | 1 |
| Takechi, S | 1 |
| Fujishima, M | 1 |
| Shoji, T | 1 |
| Nakanishi, I | 1 |
| Togawa, M | 1 |
| Hori, M | 1 |
| Tsubakihara, Y | 1 |
| Masaki, T | 1 |
| Yorioka, N | 1 |
| Yamakido, M | 1 |
| Coppo, R | 1 |
| Amore, A | 1 |
| Hogg, R | 1 |
| Emancipator, S | 1 |
| Kanmatsuse, K | 2 |
| Liao, J | 1 |
| Hayashi, K | 1 |
| Ushijima, H | 1 |
| Kimura, J | 1 |
| Hwang, YC | 1 |
| Kim, MJ | 1 |
| Yang, MH | 1 |
| McIntyre, CW | 1 |
| Fluck, RJ | 1 |
| Lambie, SH | 1 |
| Furuta, T | 1 |
| Horigome, I | 1 |
| Chiba, S | 1 |
| Noshiro, H | 1 |
| Satoh, M | 1 |
| Honda, S | 1 |
| Haramaki, R | 1 |
| Fujisawa, M | 1 |
| Ikedo, H | 1 |
| Haramaki, N | 1 |
| Ballardie, FW | 1 |
| Roberts, ISD | 1 |
| Harmankaya, O | 1 |
| Oztürk, Y | 1 |
| Baştürk, T | 1 |
| Obek, A | 1 |
| Kiliçarslan, I | 1 |
| Oviasu, E | 1 |
| Azuma, T | 1 |
| Ohashi, T | 1 |
| Shimokawahara, H | 1 |
| Fukumoto, M | 1 |
| Azuma, K | 1 |
| Uchida, Y | 1 |
| Tokuda, Y | 1 |
| Yasumoto, Y | 1 |
| Yamashita, W | 1 |
| Harada, R | 1 |
| Moriya, T | 1 |
| Nakazawa, K | 1 |
| Itoh, N | 1 |
| Shigematsu, H | 1 |
| Higuchi, M | 1 |
| Miyasaka, M | 1 |
| Oguchi, H | 1 |
| Yoshimura, M | 1 |
| Kida, H | 1 |
| Saito, Y | 1 |
| Takaeda, M | 1 |
| Sugioka, G | 1 |
| Kato, A | 1 |
| Arai, T | 1 |
| Iketani, M | 1 |
| Praderio, L | 1 |
| Corti, C | 1 |
| Sposato, E | 1 |
| Taccagni, GL | 1 |
| Volpi, A | 1 |
| Sabbadini, MG | 1 |
| Nishioka, N | 1 |
| Nasu, K | 1 |
| Hoshizaki, H | 1 |
| Sasaki, M | 1 |
| Kihara, T | 1 |
| Latt, KM | 1 |
| Ikehara, S | 1 |
| Cheng, IK | 1 |
| Chan, KW | 2 |
| Chan, MK | 1 |
| Piccoli, A | 1 |
| Borsatti, A | 1 |
| Maher, ER | 1 |
| Sweny, P | 1 |
| Chappel, M | 1 |
| Varghese, Z | 1 |
| Moorhead, JF | 1 |
| Soejima, A | 1 |
| Nakabayasi, K | 1 |
| Kitamoto, K | 1 |
| Nagasawa, T | 1 |
| Kozaki, M | 1 |
| Fujii, K | 4 |
| Kurokawa, A | 3 |
| Kamiyama, M | 2 |
| Oohashi, T | 1 |
| Kamiyana, M | 1 |
| Lai, KN | 1 |
| Lai, FM | 1 |
| Ho, CP | 1 |
| Belovezhdov, N | 1 |
| Kawaguchi, S | 1 |
| Matsuzaki, T | 1 |
| Sato, R | 1 |
| Katsumata, Y | 2 |
| Hoshino, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS)[NCT04937907] | Phase 2 | 50 participants (Anticipated) | Interventional | 2021-09-08 | Recruiting | ||
| Phase IV Open Label Uncontrolled Trial of the Dual Blockade of the Renin Angiotensin System With Enalapril Plus Valsartan Combined With Oral Methylprednisolone for the Treatment of Proteinuria in IGA Nephropathy[NCT00367562] | Phase 4 | 20 participants | Interventional | 1996-01-31 | Completed | ||
| Effect and Security of Steroids Therapy for Patients of IgA Nephropathy With Crescents : A Prospective, Randomized, Controlled, Multi-Center Clinical Trial.[NCT04833374] | Phase 3 | 200 participants (Anticipated) | Interventional | 2021-05-24 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for prednisolone and Berger Disease
| Article | Year |
|---|---|
Juvenile dermatomyositis with IgA nephropathy: case-based review.
Topics: Antirheumatic Agents; Child; Dermatomyositis; Glomerulonephritis, IGA; Glucocorticoids; Humans; Male | 2019 |
[Treatment of childhood IgA nephropathy].
Topics: Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Glomeruloneph | 2008 |
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Topics: Adolescent; Anticoagulants; Azathioprine; Cell Proliferation; Child; Dipyridamole; Disease Progressi | 2011 |
[IgA-nephropathy: the most common type of glomerulonephritis].
Topics: Age Factors; Angiotensin-Converting Enzyme Inhibitors; Diagnosis, Differential; Drug Therapy, Combin | 2003 |
Nephrotic syndrome and IgA nephropathy in polycystic kidney disease.
Topics: Aged; Biopsy; Dipyridamole; Glomerulonephritis, IGA; Humans; Kidney; Losartan; Male; Nephrotic Syndr | 2006 |
[Randomized controlled clinical trials for IgA nephropathies].
Topics: Anti-Inflammatory Agents; Disease Progression; Drug Administration Schedule; Drug Therapy, Combinati | 2007 |
[Diagnosis and therapy of glomerulonephritis and nephrotic syndrome].
Topics: Adult; Antihypertensive Agents; Cyclophosphamide; Cyclosporine; Dietary Proteins; Female; gamma-Glob | 1995 |
[Pathogenesis and therapy of IgA nephropathy].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Dietary Proteins; Glomerulonephritis, IGA; Humans | 1994 |
Mesangial immunoglobulin A deposition and focal glomerulosclerosis in a renal transplant patient with nephrotic syndrome--Berger's disease alone or superimposition of focal glomerulosclerosis?
Topics: Cyclosporine; Diagnosis, Differential; Female; Glomerular Mesangium; Glomerulonephritis; Glomerulone | 1993 |
[Physiopathology and therapy of IgA nephropathy].
Topics: Adult; Anti-Inflammatory Agents; Diet, Sodium-Restricted; Dietary Proteins; Female; Glomerulonephrit | 1996 |
IgA nephropathy (IgAN) presenting with the nephrotic syndrome.
Topics: Adult; Biopsy; Glomerulonephritis, IGA; Humans; Kidney Function Tests; Male; Nephrotic Syndrome; Pre | 1992 |
31 trials available for prednisolone and Berger Disease
| Article | Year |
|---|---|
Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Topics: Adolescent; Biopsy; Child; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Gl | 2018 |
Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antiviral Agents; Carrier State; Drug Therapy | 2014 |
Pathological sub-analysis of a multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy versus steroid pulse monotherapy in patients with immunoglobulin A nephropathy.
Topics: Adolescent; Adult; Aged; Child; Combined Modality Therapy; Female; Glomerulonephritis, IGA; Glucocor | 2016 |
Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study.
Topics: Administration, Oral; Adolescent; Adult; Combined Modality Therapy; Creatinine; Female; Glomerulonep | 2008 |
Evidence for abundant presence of chymase-positive mast cells in the kidneys of patients with immunoglobulin A nephropathy: effect of combination therapy with prednisolone and angiotensin II receptor blocker valsartan.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antihypertensi | 2008 |
Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Creatinine; Disease Progres | 2009 |
Long-term results of a randomized controlled trial in childhood IgA nephropathy.
Topics: Adolescent; Anticoagulants; Azathioprine; Cell Proliferation; Child; Dipyridamole; Disease Progressi | 2011 |
Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.
Topics: Adult; Anti-Inflammatory Agents; Arterial Pressure; Cohort Studies; Disease Progression; Female; Fol | 2012 |
Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy.
Topics: Adult; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Kidney; Male; Middle Aged; Predniso | 2003 |
Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Creatinine; Cyclo | 2003 |
A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Topics: Adolescent; Adult; Aged; Anticoagulants; Biopsy; Blood Pressure; Child; Creatinine; Female; Glomerul | 2003 |
The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Topics: Adult; Anti-Inflammatory Agents; Blood Pressure; Creatinine; Female; Glomerulonephritis, IGA; Humans | 2004 |
Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Female; Follow-Up Studies; Glomerulonephri | 2004 |
Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Drug Therapy, Combination; Female; Glomerulonephriti | 2007 |
Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Topics: Azathioprine; Child; Dipyridamole; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Male; P | 2006 |
Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Topics: Administration, Oral; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2007 |
Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Topics: Biopsy; Child; Dipyridamole; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, IGA | 2008 |
Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center.
Topics: Adult; Biopsy; Creatinine; Dose-Response Relationship, Drug; Female; Glomerulonephritis, IGA; Glucoc | 2008 |
Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dipyridamole; Disease Prog | 1996 |
[Study on a predictive marker for evaluating the effectiveness of steroid therapy in IgA nephropathy-significance of extracapillary changes].
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Female; Glomerulonephritis, IGA; Humans; Kidn | 1996 |
Interleukin 10 inhibits vascular permeability factor release by peripheral blood mononuclear cells in patients with lipoid nephrosis.
Topics: Adolescent; Adult; Endothelial Growth Factors; Female; Glomerulonephritis, IGA; Glucocorticoids; Hum | 1997 |
Age-related histologic alterations after prednisolone therapy in children with IgA nephropathy.
Topics: Adolescent; Age of Onset; Anti-Inflammatory Agents; Biopsy, Needle; Child; Female; Glomerular Mesang | 1998 |
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group.
Topics: Adolescent; Azathioprine; Blood Urea Nitrogen; Child; Dipyridamole; Drug Therapy, Combination; Glome | 1999 |
Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?
Topics: Adult; Anticoagulants; Azathioprine; Child; Dipyridamole; Drug Therapy, Combination; Glomerulonephri | 1999 |
[Assessment of adrenal function on steroid using renal diseases in children using the modified original ACTH tolerance test: comparing nephrotic syndrome with non-nephrotic syndrome].
Topics: Adolescent; Adrenal Cortex; Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Anti-Inflamm | 1999 |
Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy.
Topics: Adult; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Male; Prednisolone; Prospective Stu | 2000 |
The influence of steroid therapy in patients with IgA nephropathy.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Biopsy, Needle; Blood Pressure; Blood Urea Nitrogen; Cr | 2000 |
Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
Topics: Adolescent; Adult; Dilazep; Female; Glomerulonephritis; Glomerulonephritis, IGA; Humans; Immunohisto | 2001 |
Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.
Topics: Adult; Azathioprine; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Erythr | 2002 |
[Effects of steroid therapy in IgA nephropathy].
Topics: Adolescent; Adult; Biopsy; Child; Creatinine; Female; Glomerulonephritis, IGA; Humans; Male; Middle | 1992 |
Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Clinical Trials as Topic; Female; Glomerulonep | 1986 |
106 other studies available for prednisolone and Berger Disease
| Article | Year |
|---|---|
A case of pathologically confirmed streptococcal infection-related IgA vasculitis with associated glomerulonephritis and leukocytoclastic cutaneous vasculitis.
Topics: Aged; Aged, 80 and over; Female; Glomerulonephritis; Glomerulonephritis, IGA; Humans; IgA Vasculitis | 2022 |
Mizoribine halts kidney fibrosis in childhood IgA nephropathy: association with modulation of M2-type macrophages.
Topics: Child; Fibrosis; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidney Glomerulus; Macrophages; | 2023 |
IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.
Topics: Azathioprine; Glomerulonephritis; Glomerulonephritis, IGA; Granulocyte Colony-Stimulating Factor; Hu | 2023 |
IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.
Topics: Azathioprine; Glomerulonephritis; Glomerulonephritis, IGA; Granulocyte Colony-Stimulating Factor; Hu | 2023 |
IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.
Topics: Azathioprine; Glomerulonephritis; Glomerulonephritis, IGA; Granulocyte Colony-Stimulating Factor; Hu | 2023 |
IgA nephropathy diagnosed as a result of acute exacerbation due to G-CSF administration.
Topics: Azathioprine; Glomerulonephritis; Glomerulonephritis, IGA; Granulocyte Colony-Stimulating Factor; Hu | 2023 |
Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
Topics: Adrenal Cortex Hormones; Adult; China; Disease Progression; Female; Glomerular Filtration Rate; Glom | 2020 |
IgA nephropathy associated with thalassemia: a case report.
Topics: Adult; alpha-Thalassemia; Angiotensin Receptor Antagonists; Female; Folic Acid; Glomerulonephritis, | 2020 |
ANCA vasculitis and IgA nephropathy linked to silica exposure.
Topics: Acute Kidney Injury; Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, | 2020 |
Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Complement System Proteins; Female; Glome | 2020 |
Impact of the number of steroid pulses in tonsillectomy combined with steroid pulse therapy: a nationwide retrospective study in Japan.
Topics: Adrenal Cortex Hormones; Adult; Combined Modality Therapy; Creatine; Disease Progression; Female; Gl | 2021 |
Ulcerative IgA vasculitis in the setting of warfarin therapy.
Topics: Anticoagulants; Atrial Fibrillation; Drug Substitution; Enoxaparin; Female; Glomerulonephritis, IGA; | 2020 |
Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function.
Topics: Adult; Anti-Inflammatory Agents; Conservative Treatment; Disease Progression; Female; Glomerular Fil | 2021 |
Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice.
Topics: Adrenal Glands; Adult; Androgens; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunolo | 2017 |
Successfully chest irradiation for an advanced squamous cell lung cancer patient with predialysis renal insufficiency.
Topics: Carcinoma, Squamous Cell; Glomerulonephritis, IGA; Glucocorticoids; Humans; Lung Neoplasms; Male; Mi | 2017 |
Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Biopsy; Child; Complement C3; D | 2018 |
Drug-induced hypersensitivity syndrome followed by chronic inflammatory demyelinating polyneuropathy.
Topics: Anti-Bacterial Agents; Drug Hypersensitivity Syndrome; Glomerulonephritis, IGA; Humans; Magnetic Res | 2018 |
Steroid pulse therapy transiently destroys the discriminative histological structure of tonsils in IgA nephropathy: Tonsillectomy should be performed before or just after steroid pulse therapy.
Topics: Adult; Female; Germinal Center; Glomerulonephritis, IGA; Glucocorticoids; Humans; Japan; Male; Middl | 2018 |
Renal involvement in primary Sjogren's syndrome: a prospective cohort study.
Topics: Acidosis, Renal Tubular; Adult; Asymptomatic Diseases; Biopsy; Case-Control Studies; Female; Glomeru | 2018 |
Association between renal outcome and the number of steroid pulse therapies after tonsillectomy in patients with IgA nephropathy.
Topics: Adult; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Methylprednisolone | 2019 |
Tonsillectomy plus steroid pulse therapy is the most effective treatment in adult patients with C-Grade I IgA nephropathy, and the weight of the extracted palatine tonsils and Yamamoto scale have no significant correlation with the effects of this treatme
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Female; Glomerulonephritis, IGA; Glucocortico | 2019 |
Is Dose Adjustment of Prednisolone Required in Patients With IgA Nephropathy During Rifampicin Treatment for Mycobacterium avium Complex Lung Disease?
Topics: Aged; Antitubercular Agents; Female; Glomerulonephritis, IGA; Humans; Lung Diseases; Male; Middle Ag | 2019 |
Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study.
Topics: Adrenal Cortex Hormones; Adult; Case-Control Studies; Female; Glomerular Filtration Rate; Glomerulon | 2019 |
Nationwide survey on current treatments for IgA nephropathy in Japan.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Chi | 2013 |
Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
Topics: Adult; Anti-Inflammatory Agents; Combined Modality Therapy; Creatinine; Female; Glomerulonephritis, | 2013 |
Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy.
Topics: Adult; Female; Glomerulonephritis, IGA; Humans; Male; Methylprednisolone; Prednisolone; Pulse Therap | 2014 |
Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
Topics: Age of Onset; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Calgranulin A; Calgra | 2014 |
CMV sinusitis in a HIV-negative renal transplant recipient.
Topics: Antibodies, Monoclonal; Basiliximab; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovi | 2014 |
Tubulointerstitial nephritis and uveitis syndrome complicated by IgA nephropathy and Graves' disease: a case report.
Topics: Antithyroid Agents; Biopsy; Female; Glomerulonephritis, IGA; Glucocorticoids; Graves Disease; Humans | 2014 |
IgA-dominant postinfectious glomerulonephritis associated with Escherichia coli infection caused by cholangitis.
Topics: Aged; Biopsy; Cholangitis; Diabetes Mellitus, Type 2; Escherichia coli Infections; Glomerulonephriti | 2014 |
Absence of mesangial C1q deposition is associated with resolution of proteinuria and hematuria after tonsillectomy plus steroid pulse therapy for immunoglobulin a nephropathy.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Cohort Studies; Complement C1q; Female; Glomerula | 2015 |
Combination of pulse cyclophosphamide and steroids in crescentic IgA nephropathy.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cyclophosphamide; Disease Progression; Drug Therapy, Co | 2015 |
Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
Topics: Adult; Anti-Inflammatory Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gl | 2015 |
Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Biopsy; Chi-Square Distributio | 2017 |
IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Topics: Age of Onset; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Glomerulonephritis, IGA; Hu | 2017 |
A novel case of renal pathergy reaction in a Behçet's disease patient complicated by IgA vasculitis.
Topics: Behcet Syndrome; Colchicine; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Kid | 2017 |
Crescentic IgA nephropathy in a child: Effect of a new combination therapy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory | 2017 |
The improvement of renal survival with steroid pulse therapy in IgA nephropathy.
Topics: Adrenal Cortex Hormones; Adult; Female; Glomerulonephritis, IGA; Humans; Kidney Failure, Chronic; Ma | 2008 |
Acute poststreptococcal glomerulonephritis superimposed on IgA nephropathy.
Topics: Acute Disease; Adult; Biopsy; Diagnosis, Differential; Glomerulonephritis; Glomerulonephritis, IGA; | 2008 |
Minimal change disease versus IgA nephropathy.
Topics: Glomerulonephritis, IGA; Hepatitis, Viral, Human; Humans; Male; Middle Aged; Nephrosis, Lipoid; Pred | 2009 |
A ball-shaped thrombus of the tricuspid valve after VSD closure.
Topics: Adult; Cardiac Surgical Procedures; Glomerulonephritis, IGA; Glucocorticoids; Heart Septal Defects, | 2009 |
Primary Sjögren syndrome that developed after IgA nephropathy.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Infla | 2010 |
Clinical effectiveness of steroid pulse therapy combined with tonsillectomy in patients with immunoglobulin A nephropathy presenting glomerular haematuria and minimal proteinuria.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Female; Glomerulonephritis, IGA; Glucocorticoids | 2010 |
Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy.
Topics: Anti-Inflammatory Agents; Anticoagulants; Azathioprine; Child; Dipyridamole; Drug Therapy, Combinati | 2011 |
[Two cases of rapidly progressive nephritic syndrome complicated with alcoholic liver cirrhosis].
Topics: Adult; Disease Progression; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Immunoglobul | 2011 |
A case of Henoch-Schoenlein purpura nephritis recurring after 3 years remission.
Topics: Child; Female; Glomerulonephritis, IGA; Humans; IgA Vasculitis; Plasmapheresis; Prednisolone; Recurr | 2010 |
[Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease].
Topics: Castleman Disease; Glomerulonephritis, IGA; Humans; Interleukin-6; Male; Methylprednisolone; Middle | 2011 |
Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients.
Topics: Adult; B-Lymphocytes; Blotting, Western; Case-Control Studies; Dendritic Cells; Female; Flow Cytomet | 2012 |
Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy.
Topics: Adult; Age Factors; Aged, 80 and over; Combined Modality Therapy; Female; Glomerulonephritis, IGA; H | 2012 |
Validity of the Oxford classification of IgA nephropathy in children.
Topics: Adolescent; Age of Onset; Anti-Inflammatory Agents; Biopsy; Child; Child, Preschool; Cohort Studies; | 2012 |
A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.
Topics: Female; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Kidney Failure, Chroni | 2012 |
A typical Wegeners granulomatosis -- but not pauci-immune!
Topics: Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Fol | 2012 |
Tonsillectomy and IgA nephritis.
Topics: Anti-Inflammatory Agents; Female; Glomerulonephritis, IGA; Humans; Male; Prednisolone; Tonsillectomy | 2012 |
Bronchial asthma developing after 15 years of immunosuppressive treatment following renal transplantation.
Topics: Adult; Asthma; Azathioprine; Cyclosporine; Female; Glomerulonephritis, IGA; Humans; Immunosuppressiv | 2012 |
An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications.
Topics: Adolescent; Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; A | 2002 |
An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy.
Topics: Azathioprine; Drug Administration Schedule; Female; Glomerulonephritis; Glomerulonephritis, IGA; Gra | 2002 |
Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
Topics: Adult; Azathioprine; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up St | 2003 |
Treating IgA Nephropathy - Who, When and How?.
Topics: Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Cyclophospha | 2003 |
Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy.
Topics: Adult; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Ext | 2003 |
Effect of corticosteroid and cyclophosphamide in IgA nephropathy patients with heavy proteinuria and/or moderate-severe pathological changes.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Glucocorticoids | 2003 |
Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.
Topics: Basement Membrane; Case-Control Studies; Epithelial Cells; Glomerulonephritis, IGA; Glucocorticoids; | 2004 |
[Steroid pulse therapy combined with tonsillectomy in a patient with IgA nephropathy complicated with tuberculous pleurisy].
Topics: Adult; Female; Glomerulonephritis, IGA; Humans; Methylprednisolone; Prednisolone; Pulse Therapy, Dru | 2005 |
Coexistence of IgA nephropathy and undifferentiated spondyloarthropathy in a female patient.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Drug Therapy, Combination; Female; Glomerulonephrit | 2006 |
Unusual presentation of IgA nephropathy in childhood: a case report.
Topics: Biopsy, Needle; Captopril; Child, Preschool; Cyclophosphamide; Diagnosis, Differential; Dose-Respons | 2005 |
A case of sarcoidosis in a patient with IgA nephropathy.
Topics: Adult; Bronchi; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Kidney; Prednisolone; Sarc | 2005 |
Tonsillar focal infectious disease involving IgA nephropathy, pustulosis, and ossification.
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Focal Infection; Glomerulonephritis, IGA; Human | 2007 |
Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
Topics: Glomerulonephritis, IGA; Glucocorticoids; Humans; Male; Middle Aged; Prednisolone; Uveomeningoenceph | 2007 |
Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy.
Topics: Adolescent; Child; Drug Resistance; Female; Glomerulonephritis, IGA; Hematuria; Humans; Immunosuppre | 2008 |
Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide.
Topics: Adult; Creatinine; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Drug Therapy | 2007 |
MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomy.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Female; Glomerulonephritis, IGA; Glucocorticoids; Hae | 2007 |
[Guidelines for the treatment of childhood IgA nephropathy].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; C | 2008 |
Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy.
Topics: Adult; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow | 2008 |
Correlation between histologic features and glomerular permeability in membranous nephropathy and immunoglobulin A nephropathy.
Topics: Adolescent; Adult; Aged; Dextrans; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Glom | 1994 |
Pulmonary hemorrhage in children with glomerulonephritis.
Topics: Adolescent; Anti-Inflammatory Agents; Cyclophosphamide; Female; Glomerulonephritis, IGA; Hemorrhage; | 1995 |
[Study on platelet-derived growth factor (PDGF) and PDGF receptor expression in glomeruli and corticosteroid therapy in IgA nephropathy].
Topics: Adult; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Male; Pl | 1994 |
Combined therapy in children and adolescents with IgA nephropathy.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Fema | 1994 |
IgA nephropathy in a patient with unilateral renal agenesis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Child; Complement System Proteins; Glomerular Mesan | 1996 |
Rapidly progressive renal failure occurring in the course of pyoderma gangrenosum and IgA (lambda) monoclonal gammopathy.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Im | 1997 |
Interleukin-13 inhibits cytokine secretion by blood monocytes from patients with IgA nephropathy.
Topics: Adolescent; Adult; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Glomerulonephritis, I | 1997 |
Clinical assessment of the significance of platelet-derived growth factor in patients with immunoglobulin A nephropathy.
Topics: Adolescent; Adult; Creatinine; DNA Primers; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans | 1997 |
[A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)].
Topics: Adult; Azathioprine; Drug Administration Schedule; Female; Glomerulonephritis, IGA; Graft Rejection; | 1997 |
Steroid-sensitive nephrotic syndrome, sarcoidosis and thyroiditis--a new syndrome?
Topics: Chronic Disease; Glomerulonephritis, IGA; Glucocorticoids; Humans; Kidney; Lung Diseases; Male; Midd | 1999 |
Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Cyclophosphamide; Disease Progression; Drug Thera | 2000 |
Idiopathic nephropathy with IgA deposits.
Topics: Abdominal Pain; Child; Complement C3; Complement C4; Glomerulonephritis, IGA; Hematuria; Humans; Imm | 2000 |
Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
Topics: Adult; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Glomerulonephritis, IG | 2001 |
Elevated interleukin-18 levels in the urine of nephrotic patients.
Topics: Adult; Complement System Proteins; Female; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Interl | 2001 |
Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice.
Topics: Animals; Drug Delivery Systems; Female; Fluorescent Antibody Technique; Fluorescent Dyes; Glomerulon | 2001 |
Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cyclophosphamide; Drug Therapy, C | 2001 |
Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Azathioprine; Biopsy; Creatinine; Cyclophosphamide; D | 2001 |
Steroid pulse therapy combined with tonsillectomy in IgA nephropathy associated with diabetes mellitus.
Topics: Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabeti | 2001 |
Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
Topics: Adolescent; Adult; Azathioprine; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administrati | 2002 |
[Progress on diagnosis and therapy of kidney diseases associated with Schönlein-Henoch purpura].
Topics: Cyclophosphamide; Dietary Proteins; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; IgA | 1992 |
A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
Topics: Adolescent; Basement Membrane; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; Fu | 1992 |
[Effects of methylprednisolone pulse therapy on progressive IgA nephropathy].
Topics: Administration, Oral; Adolescent; Adult; Drug Evaluation; Female; Glomerular Filtration Rate; Glomer | 1991 |
[A case of IGA nephropathy complicated with membranous nephropathy].
Topics: Adult; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Immunoglobulin A; Immunoglob | 1991 |
Berger's disease with polyarteritis nodosa.
Topics: Adolescent; Biopsy; Blood Vessels; Glomerulonephritis, IGA; Humans; Kidney; Male; Polyarteritis Nodo | 1989 |
[Bullous pemphigoid associated with IgA nephropathy: a case report].
Topics: Aged; Glomerulonephritis, IGA; Humans; Male; Nephrotic Syndrome; Pemphigoid, Bullous; Prednisolone; | 1989 |
Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: disappearance of mesangial IgA deposits following steroid-induced remission.
Topics: Adult; Biopsy; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Kidn | 1989 |
Early steroid therapy in IgA nephropathy: still an open question.
Topics: Glomerulonephritis, IGA; Humans; Prednisolone; Proteinuria; Statistics as Topic; Time Factors | 1989 |
Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Creatinine; Cyclophosphamide; Cyclosporins; Drug Resista | 1988 |
[IgA nephropathy in a patient with ulcerative colitis].
Topics: Adult; Colitis, Ulcerative; Glomerulonephritis, IGA; Humans; Kidney; Male; Prednisolone | 1988 |
Effect of corticosteroids on renal function in progressive IgA nephropathy--long-term follow-up study.
Topics: Adult; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Kidney; Male; Prednisolone; Prote | 1988 |
[A clinico-pathological study on a long-term outcome of IgA nephropathy].
Topics: Adolescent; Adult; Child; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Kidney; Male; | 1988 |
Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Creatinine; Female; Glomerulonephritis, IGA; Humans; Kid | 1988 |
IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Follow-Up Studies; Glomerul | 1987 |
Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
Topics: Adult; Female; Glomerulonephritis, IGA; Humans; Kidney; Male; Pilot Projects; Prednisolone; Prospect | 1986 |
[Differentiated pathogenetic therapy of glomerulonephritis].
Topics: Adrenal Cortex Hormones; Anticoagulants; Azathioprine; Chronic Disease; Drug Evaluation; Drug Therap | 1987 |
[Concomitant therapy with prednisolone and cyclophosphamide in 18 cases of IgA nephropathy].
Topics: Adolescent; Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Hum | 1986 |
Concomitant therapy with prednisolone and cyclophosphamide in 17 cases with IgA nephropathy.
Topics: Administration, Oral; Adolescent; Adult; Child; Cyclophosphamide; Drug Therapy, Combination; Female; | 1985 |